{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:11:06Z","timestamp":1769022666622,"version":"3.49.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61575058"],"award-info":[{"award-number":["61575058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Graduate Innovation Fund of Harbin Medical University","award":["YJSSJCX2019-09HYD"],"award-info":[{"award-number":["YJSSJCX2019-09HYD"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>m6A RNA methylation is an emerging epigenetic modification, and its potential role in immunity and stemness remains unknown. Based on 17 widely recognized m6A regulators, the m6A modification patterns and corresponding characteristics of immune infiltration and stemness of 1152 low-grade glioma samples were comprehensively analyzed. Machine-learning strategies for constructing m6AScores were trained to quantify the m6A modification patterns of individual samples. Here, we reveal a significant correlation between the multi-omics data of regulators and clinicopathological parameters. We identified two distinct m6A modification patterns (an immune-activated differentiation pattern and an immune-desert dedifferentiation pattern) and four regulatory patterns of m6A methylation on immunity and stemness. We show that the m6AScores can predict the molecular subtype of low-grade glioma, the abundance of immune infiltration, the enrichment of signaling pathways, gene variation and prognosis. The concentration of high immunogenicity and clinical benefits in the low-m6AScore group confirmed the sensitive response to radio-chemotherapy and immunotherapy in patients with high-m6AScore. The results of the pan-cancer analyses illustrate the significant correlation between m6AScore and clinical outcome, the burden of neoepitope, immune infiltration and stemness. The assessment of individual tumor m6A modification patterns will guide us in improving treatment strategies and developing objective diagnostic tools.<\/jats:p>","DOI":"10.1093\/bib\/bbab013","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T10:10:07Z","timestamp":1610187007000},"source":"Crossref","is-referenced-by-count":65,"title":["m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma"],"prefix":"10.1093","volume":"22","author":[{"given":"Jianyang","family":"Du","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China"}]},{"given":"Hang","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China"}]},{"given":"Shuai","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"}]},{"given":"Jiaqi","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China"}]},{"given":"Shan","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China"}]},{"given":"Kuiyuan","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China"}]},{"given":"Jiawei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China"}]},{"given":"Chaochao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, First Hospital of Jilin University, Changchun 130000, China"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China"}]},{"given":"Shaoshan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"}]}],"member":"286","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"2021090815130450400_ref1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"M(6)a modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"2021090815130450400_ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"2021090815130450400_ref3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)a\/MYC\/CEBPA Signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"2021090815130450400_ref4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"2021090815130450400_ref5","doi-asserted-by":"crossref","first-page":"11356","DOI":"10.1093\/nar\/gkx778","article-title":"N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3\u2032-end processing","volume":"45","author":"Bartosovic","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2021090815130450400_ref6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"2021090815130450400_ref7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/cr.2014.151","article-title":"FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis","volume":"24","author":"Zhao","year":"2014","journal-title":"Cell Res"},{"key":"2021090815130450400_ref8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1126\/science.1261417","article-title":"Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation","volume":"347","author":"Geula","year":"2015","journal-title":"Science"},{"key":"2021090815130450400_ref9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"2021090815130450400_ref10","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"2021090815130450400_ref11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nature21671","article-title":"RNA m(6)a methylation regulates the ultraviolet-induced DNA damage response","volume":"543","author":"Xiang","year":"2017","journal-title":"Nature"},{"key":"2021090815130450400_ref12","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","article-title":"Glioma","volume":"1","author":"Weller","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2021090815130450400_ref13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2021090815130450400_ref14","doi-asserted-by":"crossref","first-page":"558961","DOI":"10.3389\/fcell.2020.558961","article-title":"Identification of prognostic model and biomarkers for cancer stem cell characteristics in glioblastoma by network analysis of multi-omics data and Stemness indices","volume":"8","author":"Du","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2021090815130450400_ref15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)a)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat Med"},{"key":"2021090815130450400_ref16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","article-title":"M(6)a mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer","volume":"20","author":"Liu","year":"2018","journal-title":"Nat Cell Biol"},{"key":"2021090815130450400_ref17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m(6)a RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol Cancer"},{"key":"2021090815130450400_ref18","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1128-6","article-title":"M(6)a demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling","volume":"19","author":"Tang","year":"2020","journal-title":"Mol Cancer"},{"key":"2021090815130450400_ref19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine learning identifies Stemness features associated with oncogenic dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"},{"key":"2021090815130450400_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett"},{"key":"2021090815130450400_ref21","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"M(6)a mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat Commun"},{"key":"2021090815130450400_ref22","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"M(6)a RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells","volume":"18","author":"Cui","year":"2017","journal-title":"Cell Rep"},{"key":"2021090815130450400_ref23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid Leukemia as a N(6)-Methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"2021090815130450400_ref24","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2021090815130450400_ref25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0331","article-title":"The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells","author":"Dixit","year":"2020","journal-title":"Cancer Discov"},{"key":"2021090815130450400_ref26","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-13-2625","article-title":"Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence","volume":"74","author":"Nissan","year":"2014","journal-title":"Cancer Res"},{"key":"2021090815130450400_ref27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"2021090815130450400_ref28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"2021090815130450400_ref29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12943-019-1116-x","article-title":"M(6)a modification-mediated CBX8 induction regulates stemness and chemosensitivity of colon cancer via upregulation of LGR5","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol Cancer"},{"key":"2021090815130450400_ref30","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"2021090815130450400_ref31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-017-0410-6","article-title":"Genetic alterations of m(6)a regulators predict poorer survival in acute myeloid leukemia","volume":"10","author":"Kwok","year":"2017","journal-title":"J Hematol Oncol"},{"key":"2021090815130450400_ref32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jama.2019.10650","article-title":"Association between FDA label restriction and immunotherapy and chemotherapy use in bladder cancer","volume":"322","author":"Parikh","year":"2019","journal-title":"JAMA"},{"key":"2021090815130450400_ref33","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2021090815130450400_ref34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"2021090815130450400_ref35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2021090815130450400_ref36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nsmb.2096","article-title":"Unraveling the mechanism of BRCA2 in homologous recombination","volume":"18","author":"Holloman","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"2021090815130450400_ref37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"2021090815130450400_ref38","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","article-title":"The critical role of RNA m(6)a methylation in cancer","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res"},{"key":"2021090815130450400_ref39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cancers12030736","article-title":"The emerging roles of RNA modifications in glioblastoma","volume":"12","author":"Dong","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2021090815130450400_ref40","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-18-2868","article-title":"N(6)-Methyladenosine modulates nonsense-mediated mRNA decay in human glioblastoma","volume":"79","author":"Li","year":"2019","journal-title":"Cancer Res"},{"key":"2021090815130450400_ref41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fonc.2020.00208","article-title":"Malignant evaluation and clinical prognostic values of m6A RNA methylation regulators in glioblastoma","volume":"10","author":"Du","year":"2020","journal-title":"Front Oncol"},{"key":"2021090815130450400_ref42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","article-title":"M(6)a regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"2021090815130450400_ref43","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m(6)a methylation promotes dendritic cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"2021090815130450400_ref44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m(6)a methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"2021090815130450400_ref45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature23450","article-title":"M(6)a mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways","volume":"548","author":"Li","year":"2017","journal-title":"Nature"},{"key":"2021090815130450400_ref46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/cr.2018.7","article-title":"M(6)a mRNA methylation sustains Treg suppressive functions","volume":"28","author":"Tong","year":"2018","journal-title":"Cell Res"},{"key":"2021090815130450400_ref47","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/onc.2017.351","article-title":"Essential role of METTL3-mediated m(6)a modification in glioma stem-like cells maintenance and radioresistance","volume":"37","author":"Visvanathan","year":"2018","journal-title":"Oncogene"},{"key":"2021090815130450400_ref48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/neuonc\/nox166","article-title":"EANO guidelines for the diagnosis and treatment of ependymal tumors","volume":"20","author":"Ruda","year":"2018","journal-title":"Neuro Oncol"},{"key":"2021090815130450400_ref49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/jcm5030037","article-title":"New insights into the crossroads between EMT and Stemness in the context of cancer","volume":"5","author":"Fabregat","year":"2016","journal-title":"J Clin Med"},{"key":"2021090815130450400_ref50","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/neuonc\/noy072","article-title":"Temozolomide for immunomodulation in the treatment of glioblastoma","volume":"20","author":"Karachi","year":"2018","journal-title":"Neuro Oncol"},{"key":"2021090815130450400_ref51","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab013\/40328109\/bbab013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab013\/40328109\/bbab013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T15:19:20Z","timestamp":1631114360000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab013\/6135369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab013","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,2,17]]},"article-number":"bbab013"}}